美国食品药品局细菌分析手册(BAM)第4A章:致腹泻性大肠杆菌(2020年7月版)BAM Chapter 4A Diarrheagenic Escherichia coli

转载
来源:美国(FDA)
2025-10-27 14:34:07
16次浏览
分享:
收藏
核心提示:美国食品药品局细菌分析手册(BAM)第4A章:致腹泻性大肠杆菌(2020年7月版)。

Escherichia coli is one of the predominant species of facultative anaerobes in the human gut and usually harmless to the host; however, a group of pathogenic E. coli has emerged that causes diarrheal disease in humans. Referred to as Diarrheagenic E. coli (28) or commonly as pathogenic E. coli, these groups are classified based on their unique virulence factors and can only be identified by these traits. Hence, analysis for pathogenic E. coli often requires that the isolates be first identified as E. coli before testing for virulence markers. The pathogenic groups include enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), diffusely adherent E. coli (DAEC) and perhaps others that are not yet well characterized (21, 28). Of these, only the first 4 groups have been implicated in food or water borne illness. Some properties and symptoms of these 4 subgroups are discussed below and summarized in Table 1.

更多内容请查看附件。

 

网站声明

1、凡本网所有原始/编译文章及图片、图表的版权均属微生物安全与健康网所有,未经授权,禁止转载,如需转载,请联系取得授权后转载。

2、凡本网未注明"信息来源:(微生物安全与健康网)"的信息,均来源于网络,转载的目的在于传递更多的信息,仅供网友学习参考使用并不代表本网同意观点和对真实性负责,著作权及版权归原作者所有,转载无意侵犯版权,如有侵权,请速来函告知,我们将尽快处理。

3、转载请注明:文章转载自www.mbiosh.com

联系方式:020-87680942

评论
请先登录后发表评论~
发表评论